期刊文献+

Mirriz's综合征血清CA19-9异常升高及其在其他疾病诊断中的临床意义 被引量:2

下载PDF
导出
摘要 目的探讨血清CA19-9异常升高在疾病诊断中的临床意义。方法对1例血清CA19-9异常升高的Mirriz's综合征的临床资料进行回顾性分析。结果本例因发作性右上腹痛伴呕吐、皮肤瘙痒2周入院。曾在外院行B超检查示:胆结石、胆囊炎,予抗感染等治疗稍好转。入我院后经实验室检查、肝胆胰脾B超、上腹部增强CT+计算机体层摄影血管成像(CTA)提示胆囊及胆总管结石、胆囊炎、腹主动脉粥样硬化,进一步行磁共振胆胰管造影(MRCP)考虑Mirriz's综合征可能,查CA19-9 10 527.0 kU/L、CA50 151.3 kU/L,不排除肿瘤(胰腺癌?)可能,行手术探查胰腺未见异常,术中诊断为Mirriz's综合征,术后病理示慢性胆囊炎,术后第2天复查CA19-9 181.6 kU/L,痊愈出院。结论临床接诊上腹痛伴CA19-9异常升高者,考虑胰腺癌等恶性肿瘤同时,亦应想到良性疾病可能,以免误诊误治。
出处 《临床误诊误治》 2014年第9期104-105,共2页 Clinical Misdiagnosis & Mistherapy
基金 国家自然科学基金资助项目(81071985) 安徽省国际科技合作计划项目(1008010038) 安徽省科技攻关计划资助项目(110104022172) 2013年度安徽省科技计划重点项目(1301043013)
  • 相关文献

参考文献11

  • 1Gui J C, Yan W L, Liu X D. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis [ J ]. Clin Exp Med, 2014,14 ( 2 ) : 225-233.
  • 2武文,陈炯.胰腺癌蛋白质肿瘤标志物的研究进展[J].国际外科学杂志,2012,39(8):546-549. 被引量:2
  • 3陈炯,陈龙江.CA19-9在胰腺癌诊断中的临床价值[J].国际外科学杂志,2013,40(6):364-366. 被引量:4
  • 4Yue T, Partyka K, Maupin K A, et al. Identification of blood-protein carriers of the CA 19-9 antigen and charac- terization of prevalence in pancreatic diseases [ J ]. Pro- teomics, 2011,11 ( 18 ) : 3665-3674.
  • 5Galli C, Basso D, Plebani M. CA19-9: handle with care [J]. Clin Chem Lab Med, 2013,51(7) :1369-1383.
  • 6Sak M E, Evsen M S, Soydine H E, et al. Imperforate hymen with elevated serum CA125 and CA19-9 levels [ J ]. J Reprod Med, 2013,58 ( 1-2 ) :47-50.
  • 7Shin J Y, Yoo S J, Park B M, et al. Extremely increased serum carbohydrate antigen 19-9 levels caused by new or resistant infections to previous antibiotics in chronic lung diseases [ J ]. Tubere Respir Dis, 2013,75 ( 3 ) : 125-127.
  • 8Bertino G I, Ardiri A M, Calvagno G S, et al. Carbohy- drate 19-9 antigen serum levels in liver disease[ J]. Bi- oMed Res Int, 2013,2013:531640.
  • 9Elisei R, Lorusso L, Romei C, et al. Medullary thyroid cancer secreting carbohydrate antigen 19-9 (CA19-9) : a fatal case report[ J]. J Clin Endoerinol Metab, 2013,98 (9) :3550-3554.
  • 10Onal C, Colakoglu T, Ulusan S N, et al. Biliary obstruc- tion induces extremely elevated serum CA19-9 levels: case report[ J ]. Onkologie, 2012,35 ( 12 ) :780-782.

二级参考文献25

  • 1Shen, Yong-Mei,Yang, Xiao-Chun,Song, Miao-Li,Qin, Chen-Hao,Yang, Chen,Sun, Yi-Hui.Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells[J].Hepatobiliary & Pancreatic Diseases International,2010,9(1):69-77. 被引量:18
  • 2Liao, Quan,Zhao, Yu-Pei,Yang, Ying-Chi,Li, Li-Jun,Long, Xiao,Han, Shao-Mei.Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):641-645. 被引量:27
  • 3Hailer DG. New perspectives in the management of pancreas canc- er[J]. Semin Oncol, 2003, 30(4 Supp 11) : 3-10.
  • 4Goonetilleke KS, Siriwardena AK. Systematic review of carbohy- drate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer [ J]. Eur J Surg Oneol, 2007, 33 (3) : 266-270.
  • 5Duraker N, Hot S, Polat Y, et al. CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic dis- eases with or without jaundice [ J ]. J Surg Oncol, 2007, 95 (2) : 142-147.
  • 6Kim YC, Kim HJ, Park JH, et al. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic ade- nocarcinoma[J]. J Gastroenterol Hepatol, 2009, 24(12): 1869- 1875.
  • 7Hartwig W, Strobel O, Hinz U, et al. CA19-9 in potentially re- sectahle pancreatic cancer: perspective to adjust surgical and perio- perative therapy I J]. Ann Surg Oncol, 2012, [ Epub ahead of print ].
  • 8Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal [ J ]. J Gastrointest Oncol, 2012, 3(2) : 105-119.
  • 9Sugiura T, Uesaka K, Kanemoto H, et al. Serum CA19-9 is a sig- nificant predictor among preoperative parameters for early recur- rence after resection of pancreatic adenocarcinoma[ J]. J Gastroint- est Surg, 2012, 16(5) : 977-985.
  • 10Ferrone CR, Finkelstein DM, Thayer SP, et al. Perioperative CA19-9 levels can predict stage and survival in patients with re- sectable pancreatic adenocarcinoma [ J ]. J Clin Oncol, 2006, 24 (18) :2897-2902.

共引文献33

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部